An Innovative Synbiotic Formulation Decreases Free Serum Indoxyl Sulfate, Small Intestine Permeability and Ameliorates Gastrointestinal Symptoms in a Randomized Pilot Trial in Stage IIIb-IV CKD Patients

Proteolytic dysbiosis of the gut microbiota has been recognized as both a typical feature of chronic kidney disease (CKD) and a risk factor for its progression. Blood accumulation of gut-derived uremic toxins (UTs) like indoxyl sulfate (IS) and p-cresyl sulfate (PCS), intestinal permeability and con...

Descripción completa

Detalles Bibliográficos
Autores principales: Cosola, Carmela, Rocchetti, Maria Teresa, di Bari, Ighli, Acquaviva, Paola Maria, Maranzano, Valentina, Corciulo, Simone, Di Ciaula, Agostino, Di Palo, Domenica Maria, La Forgia, Flavia Maria, Fontana, Sergio, De Angelis, Maria, Portincasa, Piero, Gesualdo, Loreto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147955/
https://www.ncbi.nlm.nih.gov/pubmed/34063068
http://dx.doi.org/10.3390/toxins13050334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147955/
https://www.ncbi.nlm.nih.gov/pubmed/34063068
http://dx.doi.org/10.3390/toxins13050334

Ejemplares similares